Overview

Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children

Status:
Completed
Trial end date:
2018-01-15
Target enrollment:
Participant gender:
Summary
Study where children will receive one premedication, either intranasal dexmedetomidine or oral midazolam, to reduce agitation on emergence of anesthesia. The hypothesis is that dexmedetomidine is superior but previous studies lack quality.
Phase:
Phase 3
Details
Lead Sponsor:
Brasilia University Hospital
Treatments:
Dexmedetomidine
Midazolam
Pharmaceutical Solutions